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Abstract Novel cyanide countermeasures are needed for
cases of a mass-exposure cyanide emergency. A lead
candidate compound is dimethyl trisulfide (DMTS), which
acts as a sulfur donor for rhodanese, thereby assisting the
conversion of cyanide into thiocyanate. DMTS is a safe
compound for consumption and, in a 15 % polysorbate 80
(DMTS-PS80) formulation, has demonstrated good effi-
cacy against cyanide poisoning in several animal models.
We performed a stability study that investigated the effect
of temperature, location of formulation preparation, and pH
under buffered conditions. We found that while the sta-
bility of the DMTS component was fairly independent of
which laboratory prepared the formulation, the concentra-
tion of DMTS in the formulation was reduced 36–58 %
over the course of 29 weeks when stored at room tem-
perature. This loss typically increased with increasing
temperatures, although we did not find statistical differ-
ences between the stability at different storage tempera-
tures in all formulations. Further, we found that addition of
a light buffer negatively impacted the stability, whereas the
pH of that buffer did not impact stability. We investigated
the factors behind the reduction of DMTS over time using
various techniques, and we suggest that the instability of
the formulation is governed at least partially by precipita-
tion and evaporation, although a combination of factors is
likely involved.
Key Points
Dimethyl trisulfide (DMTS) is a lead candidate
cyanide countermeasures that is safe for
consumption and has demonstrated good efficacy
against cyanide poisoning in several animal models.
We performed a stability study of a 15 %
polysorbate 80-DMTS formulation and found that a
reduction in concentration of DMTS in the
formulation (e.g., 36–58 % over the course of 29
weeks when stored at room temperature) could not
be explained by formulation storag temperature,
preparative laboratory, or formulation pH.
Based on various other analytical techniques
performed, we suggest that the instability of the
formulation is governed at least partially by
precipitation and evaporation, although a
combination of factors is likely involved.
1 Introduction
Current FDA-approved cyanide countermeasures
(CyanoKit and Nithiodote) are constrained by a require-
ment for intravenous administration, thereby severely
limiting their usefulness in a mass-exposure cyanide emer-
gency. Thus, alternatives to these countermeasures are
needed. Recently, compounds with organo-sulfur donor
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scaffolds have been explored [1]. A detailed discussion of the
current cyanide antidote research is reviewed elsewhere [2].
Mechanistically, these compounds act as sulfur donors for
rhodanese, thereby assisting the conversion of cyanide into
thiocyanate. One of the lead candidate compounds in this
group is dimethyl trisulfide (DMTS), an acyclic aliphatic
trisulfide found naturally in garlic, onions, cabbage, and
similar vegetables. DMTS is used in theUSAandEurope as a
flavor enhancer, is considered by the FDA to be ‘Generally
Recognized as Safe’ (GRAS) under conditions of intended
use, and is listed on the FDA’s ‘‘EverythingAdded to Food in
the United States’’ list. HumanDMTS intake estimates in the
USA have been reported as 0.0003 lg/kg B/day and
0.02 lg/capita/day [3].
In previous studies, neat DMTS was administered to
mice via the intramuscular route. When muscle necrosis
was observed at the injection site in a subset of these
animals, a new formulation was developed (DMTS in 15 %
polysorbate 80 [DMTS-PS80]). This formulation was
rationalized based on the improvement of the solubility,
stability, and efficacy of similar cyanide antidote com-
pounds [1]. In this new formulation, DMTS has demon-
strated efficacy against cyanide poisoning in several animal
models at a concentration of 50 mg/ml and at doses up to
100 mg/kg. Preliminary stability studies indicated that
DMTS-PS80 is relatively stable (90–95 % retention of
DMTS) out to 31 days, at various pHs at refrigerated
temperatures (Petrikovics, 2014, unpublished data).
In this study, we performed a longer-term (29 weeks),
comprehensive stability study that investigated the effect of
temperature, location of formulation preparation, and pH
under buffered conditions. Storage conditions, times, and
buffer compositions were selected to cover a range of
conditions in an exploratory and comprehensive way, and
were not meant to be a final stability testing of the for-
mulation. We used a gas chromatography-mass spectrom-
etry (GC-MS) assay to determine the concentration of
DMTS over time within the liquid formulation as well as to
identify any chemical degradation products in selected
samples. This GC-MS assay was also used to determine the
presence of evaporated DMTS and DMTS adsorbed to vial
caps during the stability study. As we noted loss in DMTS
over time, we also performed several other assays to
characterize the entire formulation. These analyses inclu-
ded nuclear magnetic resonance (NMR) to characterize
both the DMTS and PS80 components of the formulation;
size-exclusion chromatography high-performance liquid
chromatography (SEC-HPLC) and dynamic light scattering
(DLS) to characterize changes in the PS80 micellar con-
centration and size; critical micelle concentration (CMC)
assays to characterize changes in the bulk micellar con-
centration; and transmission electron microscopy (TEM) to
characterize microscopic structural changes in the formu-
lation. Here, we describe the results of these analyses and
suggest potential destabilization mechanisms.
2 Materials and Methods
2.1 Test Articles
DMTS-PS80 formulations were prepared by three different
laboratories, but all tests were performed by Battelle
(Columbus, OH, USA) (Table 1). Those formulations
prepared outside of Battelle were shipped overnight to
Battelle for testing.
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a These formulations contained 15 mM bis-tris (MP, catalog 194546, lot MR29626), 7.5 mM EPPS (Sigma, catalog E1894, lot SUBB3608 V),
and 7.5 mM CHES (Sigma, Catalog 29311, lot BCBG3190 V)
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In general, the following procedure was followed unless
otherwise noted. A 15 % (w/w) PS80 solution was made by
mixing the appropriate amount of PS80 with deionized
water or a three-component buffer consisting of 15 mM
bis-tris, 7.5 mM EPPS, and 7.5 mM CHES (pH 5.0, 7.0, or
9.0). The pH of the final water formulations was deter-
mined to be 7.0 at the start of the stability study. The
mixture was vortexed and manually shaken until the
solution was clear (typically overnight, but at least 1 h was
required for dissolution). DMTS 5 g was added to a 100-ml
volumetric flask, and 15 % PS80 was added until the total
volume reached 100 ml. This solution was vigorously
mixed via vortexing and inversion for at least 1 h until the
DMTS was completely dissolved (as judged by visual
inspection). We placed 2-ml aliquots of this 50-mg/ml
DMTS solution into 2-ml glass screw-top vials (Agilent
part no. 5182-0715 and 5182-0725). The screw-cap vial
was then placed in a secondary 5-mL glass crimp vial
(Wheaton part no. 223685 and 224100-180). The outer
crimp vial was then purged with a stream of nitrogen gas
and stoppered with a rubber stopper, and the cap was
crimped. The secondary container void volumes (volume
of secondary container minus primary container) from the
formulation A setup and the formulation B and C prepa-
rations were different. The void volumes in the outer vial
of the A samples and B samples were measured to be 9.06
and 6.34 ml, respectively. Following preparation, samples
were placed at room temperature (20 C), 2–8 C, or 40 C
in controlled and dark environments. For each formulation,
initial concentrations were determined 1 day following
sample preparation (for consistency, as some of the sam-
ples were shipped overnight to Battelle, while others were
prepared at Battelle).
2.2 Transmission Electron Microscopy (TEM)
Both negative-stain TEM and cryo-TEM were used to
obtain high-resolution images of micellar structures in
selected samples. All sample processing and imaging was
performed at the Electron Microscopy Core Facility at the
University of Massachusetts Medical School. Negative-
stain TEM was initially performed for ease of sample
preparation and to provide images with high contrast to
easily differentiate micellar structures. In brief, 5-ml
samples were spread on freshly prepared carbon-stabilized
Formvar support films (either copper or gold grids) within
an enclosed chamber with a relative humidity of 60 %.
After 30 s, the excess sample droplet was wicked away
with a wedge of filter paper. Finally, the grids were neg-
atively stained with 1 % uranyl acetate in water to contrast
the spread particle samples. The freshly prepared speci-
mens were then imaged on a FEI Tecnai 12, Spirit
BioTwin, transmission electron microscope at 80 kV
accelerating voltage, and images were recorded at 87,0009
using a Gatan Erlangshen CCD 2K camera system.
Additionally, cryo-TEM was performed to observe
micellar structures more closely associated with their
native environment since this method does not utilize
chemical preparative steps, which greatly minimizes the
level of sample artifacts. Selected samples were prepared
on Quanta foil grids obtained from Electron Microscopy
Sciences (EMS), and the entire procedure was carried out
in an enclosed chamber at a relative humidity of 60 %. A
5-ml aliquot of sample was loaded onto a Quanta foil 200
mesh grid and secured into the cryo-plunging apparatus.
Liquid ethane was then loaded into the reserve well and
frozen in a bath of liquid nitrogen at –196 C. Using a
copper rod, the ethane bath was thawed to –155 C (the
melting point of ethane). The droplet was then wicked
away with a small wedge of number 50 Whatman filter
paper, and then the grid was immediately pneumatically
plunged into the liquid ethane. Once frozen, the grid with
the frozen sample was removed from the plunging appa-
ratus and stored in a cryo-grid box in liquid nitrogen for
transport to the cryo-electron microscope. The freshly
prepared cryo-specimens were then imaged on a Philips
CM120, Cryo-transmission electron microscope at 120 kV
accelerating voltage, with the specimen stage cooled with
liquid nitrogen to –196 C. All images were recorded at
various magnifications using a Gatan Orius optically cou-
pled CCD 2K camera system.
2.3 Gas Chromatography-Mass Spectrometry (GC-
MS) Analysis of Liquid and Headspace Samples
2.3.1 Preparation of Dimethyl Trisulfide (DMTS)-
Polysorbate 80 Samples for GC-MS Analysis
An internal standard solution was prepared by mixing
41 mg of dibutyl disulfide (Sigma-Aldrich, catalog number
B93989-25ML) with 25 ml of methanol (Fisher Scientific,
catalog number A456-4). DMTS-PS80 liquid samples were
prepared for GC-MS analysis by mixing 25 ll of each
liquid sample (gently inverted several times prior to sam-
pling) with 75 ll dibutyl disulfide internal standard solu-
tion and 2.9 ml of methanol.
The headspace above select DMTS-PS80 samples and
the headspace within select secondary containers were also
evaluated using GC-MS. A Hamilton gas-tight syringe was
used to collect and inject 10 ll of each headspace sample.
Isolated precipitate samples were prepared by separating
the precipitated material from the supernatant by cen-
trifugation at 17,5309g for 15 min at room temperature
and dissolving the isolated precipitate in methanol.
The caps of select DMTS-PS80-containing glass vials
were flash frozen with liquid nitrogen, pulverized (mortar
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and pestle), and extracted for 1 h with one ml of methanol.
Each methanolic extract was analyzed using GC-MS.
2.3.2 Preparation of DMTS and Dimethyl Disulfide
(DMDS) GC-MS Calibration Standards
DMTS GC-MS calibration standard solutions, ranging
from 10 to 600 lg/ml, were prepared by mixing varying
volumes of a stock DMTS solution (5.03 mg DMTS/ml
methanol), an internal standard solution (100 ll), and
varying volumes of methanol. The following standard
concentrations were prepared: 10, 40, 80, 160, 320, 480,
and 600 lg/ml. DMDS GC-MS calibration standard solu-
tions, ranging from 10 to 600 lg/ml, were prepared in a
similar manner.
2.4 GC-MS Analyses
The GC-MS instrumentation used consisted of an Agilent
Model 6890 chromatograph, Agilent Model 7683 injector,
and Agilent Model 5973 mass selective detector. The GC
column was an Agilent HP-5MS, 30 m 9 0.25 mm with
0.25 lm film. We used Agilent ChemStation Version
D.01.02.16 software to process the data. Chromatography
analysis was conducted at 45 C for 3 min, 3 C/min to
250 C, and 250 C for 5 min with an He flow rate of 1 ml/
min. The inlet temperature was 250 C, and the injection
volume was 1 ll for liquid samples and 10 ll for head-
space samples. The MS parameters were as follows: source
temperature 230 C, quadrupole temperature 150 C, and
scan range of 45–400 m/z. The ions used for quantification
included 94 m/z (DMDS) and 126 m/z (DMTS).
2.5 Statistical Analyses of GC-MS Data
All statistical analyses were performed with SAS version
9.3. Summary statistics were produced for the mean con-
centration and 95 % confidence interval of each formula-
tion at each temperature and time point. The percent
change in DMTS concentration was calculated for each
sample of each formulation at each time point and tem-
perature combination relative to the average baseline value
for that formulation. Separate time point and temperature
analysis of variance (ANOVA) statistical models were fit to
the percent change data for all of the formulations. Least
squares means and 95 % confidence intervals were gener-
ated for each combination.
Pairwise comparisons for each time point were per-
formed using Dunnett’s procedure to generate simultane-
ous 95 % confidence intervals. The rate at which
concentration decreased as a function of time was com-
pared between formulations using a linear model. The
linear model was fit to the data such that a separate slope
and intercept was used for each of the 18 formulations and
storage temperature combinations. The linear model is of
the form
Yi ¼ b0i þ b1ixþ ei
where i ranges from 1 to 18 for each of the formulations
and storage temperature combinations, Yi represents the
concentration level (in mg/ml), b0i is the y-intercept for
combination i, b1i is the slope for combination i, x is the
number of weeks past, and ei represents the error term.
Once the slopes were generated, the rates of linear
decrease between different storage temperatures within a
given formulation as well as between different formula-
tions for a given storage temperature were compared. For
these comparisons, a two-sample test was performed for
each of the 45 combinations, and the resulting p values
were adjusted via a Bonferroni–Holm adjustment factor.
Adjusted p values are used to assure that the overall error
rate for all comparisons is no more than 0.05.
2.6 Nuclear Magnetic Resonance (NMR)
1H and 13C NMR spectra were collected on a Bruker
AVANCE 500 spectrometer equipped with a 5 mm high-
resolution broadband inverse (BBI) probe. Initially, fresh
samples were prepared in D2O, but subsequent testing
revealed that samples from the stability study described
above (non-pH samples prepared in H2O) could be directly
analyzed via 1H NMR using a solvent suppression pulse
program. For this analysis, samples were prepared by
diluting 9 parts sample with 1 part D2O to facilitate field
locking and shimming of the samples. Spectra were man-
ually interrogated for the presence of signals not derived
from the DMTS or PS80 in the formulation. For compar-
isons at different time points during the stability study,
fresh formulation controls were prepared by Battelle.
Further, DMTS concentrations from NMR spectra were
determined according to Eq. 1 under the assumption that
the PS80 signals were not diminishing over time. Con-
centration of DMTS determined by 1H NMR:
½DMTS; mg ml1
¼ 50 mg ml1 
ðDMTS Integral AreaÞ
ð# protons in DMTS SignalÞ
ðPS80 Integral AreaÞ









Where 3.6087 = the ratio of the starting molar concen-
tration of DMTS to the starting molar concentration of
PS80 (i.e., 0.396 M/0.109 M) based on the assumption of
molecular weights of DMTS and PS80 of 126.26 and
1310 Da, respectively.
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NMR analysis of a sample containing precipitate was
accomplished by separating the precipitated material from
the supernatant by centrifugation at 17,5309g for 15 min at
room temperature. This was followed by dissolution of the
precipitate in deuterated methanol. The supernatant was
diluted twofold in D2O prior to analysis.
2.7 Critical Micelle Concentration (CMC) Assay
CMCs for selected formulations were determined using the
fluorescence polarization method reported by Held et al.
[4]. This method utilizes the lipophilic probe 5-dode-
canoylaminofluorecenein (DAF), which contains a fluo-
rescent head group connected to an aliphatic tail that
becomes incorporated into detergent micelles at polysor-
bate concentrations above the CMC. When inserted into a
micelle, the fluorescence polarization increases as a result
of the inverse relationship between the emission of polar-
ized light and the probe’s rotational speed.
To perform the fluorescence polarization assays, DAF
(Life Technologies) was prepared fresh as a 5 mM stock
solution in 0.2 M KOH/methanol. In addition, a 125 mM
stock solution of HEPES buffer (pH 8) was prepared and
used as a diluent for the samples. Serial dilutions of stock
solutions were performed in Milli-Q water to achieve 14
dilutions ranging from 1 to 0.0001 % of PS80, PS20, or
PS80/DMTS formulations. Final concentrations of assay
reagents consisted of 25 mM HEPES buffer and 1 lM of
DAF in Milli-Q water. Dilutions of samples and assay
reagents were added to black Corning Costar 96-well assay
plates with clear well bottoms and mixed and then incu-
bated in the dark for approximately 30 min. Fluorescence
polarization of samples was measured in triplicate at 20 C;
measurements were acquired on a Molecular Devices
SpectraMax M5 plate reader using a 485 nm excitation and
a 535 nm emission filter. Fluorescence polarization (P)
values were plotted as a function of the detergent concen-
tration x, and a 4-parameter logistic (4-PL) curve was fit to
the data according to Eq. 2. 4PL Curve Relating Fluores-
cence Polarization to Detergent Concentration:
P ¼ A D
1þ ðx=CÞB þ 1 ð2Þ
where A is the minimum response, B is the Hill slope, C is
the half effective dose (i.e., the concentration of the
detergent at the inflection point of the curve), and D is the
maximal response. The CMC was then calculated as
the intersection (Ix) of the rapidly changing portion of the
curve and the horizontal portion at the minimal point of the
curve using the series of equations below where LS is
LogSlope, LSb is the y-intercept of the tangent line, and Ix
is the CMC. Slope of tangent line of the 4-PL Curve:
P ¼ LS Log xð Þ þ LSb ð3Þ
Definition of LogSlope (LS):
LS ¼ B D Að Þ  Lnð10Þ=4 ð4Þ
Definition of LogSlope intercept (LSb):
LSb ¼ ðAþ DÞ=2 LS LogðCÞ ð5Þ
Relationship between CMC (Ix), minimum response (A),
LS, and LSb:
A ¼ LS Log Ixð Þ þ LSb ð6Þ
CMC (Ix) Calculation based on rearrangement of Eq. 6:




SEC-HPLC was performed to determine the concentration
and integrity of PS80 in the formulation over time
according to the method reported by Tani et al. [5]. Briefly,
a standard curve that ranged from 0.5 % PS80 plus
1.67 mg/ml DMTS to 10 % PS80 plus 33 mg/ml DMTS
was used to measure micelle concentrations in samples
diluted 1.5-fold (from 15 % PS80 plus 50 mg/ml DMTS)
using a Tosoh TSKgel G2000SWXL (7.8 mm 9 30 cm,
5 lm) column and Waters 2695 HPLC with a 2487
detector. The mobile phase consisted of 10 mM sodium
phosphate, 150 mM sodium chloride, and 0.1 % PS80, pH
7.0. The flow rate, injection volume, and detection wave-
length was 1 ml/min, 2.5 ll, and 235 nm, respectively, for
this analysis. Samples and standards were filtered through a
0.2 lm PVDF filter prior to loading. For concentration
determinations of unknowns, samples were diluted 1.5-fold
to ensure concentrations were within the linear range of the
assay.
2.9 Dynamic Light Scattering (DLS)
DLS was used to measure the hydrodynamic diameter of
micelles at concentrations above the CMC for PS80 using a
BI-200SM motorized goniometer and BI-9000AT Digital
Autocorrelation (Brookhaven Instruments Corporation).
The particle size distribution data were based on weighting
of the intensity of the scattered light. The values of
effective diameter or average hydrodynamic radius and
polydispersity index were determined. Polydispersity index
is the intensity-weighted relative variance of the diffusion
coefficient and is a measure of the size distribution width.
Samples were prepared at *3 % PS80 and were not fil-
tered or vortexed prior to analysis.
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3 Results
3.1 Formulation Preparation and Visual
Observations
Because of the volatility of DMTS, formulations were
prepared in a double-vial system to reduce evaporation
(Fig. 1, and Figures S1 and S2 in the Electronic Supple-
mentary Material [ESM]). DMTS-PS80 formulations were
prepared in bulk, and 2 ml of each formulation was ali-
quoted into individual 2-ml glass vials. Following sealing,
each 2-ml filled vial was placed into an outer glass vial
(approximately 5-ml vials), purged with a stream of
nitrogen, and sealed with a rubber septum and crimp cap.
Individually sealed vials were placed at room temperature
(20 C), 4 C, or 40 C. Six different formulations were
prepared as described in Table 1. Samples were prepared
by three different laboratories using identical protocols and
formulations. Samples were prepared either without a
buffering agent (samples A, B, and C) or with a light three-
component buffer to control pH (B5, B7, and B9) as
described in the methods section.
Upon initiation of the stability study, the C formulations
had a slightly yellow appearance, with some white pre-
cipitate material in the bottom of the vials. The other for-
mulations were clear without any precipitate. However,
following a few days of incubation at all temperatures,
haziness and/or at least some white precipitate that settled
to the bottom of the vial was noticed in at least one sample
from each triplicate set of samples. The precipitate and
haziness increased with increasing temperature, as apparent
from the pictures of the A samples after 2 weeks of storage
at 40 C (Figure S1 in the ESM). No additional precipitate
was noticed for the A samples stored at 4 and 20 C after
2 weeks. Similarly, sample haziness was noticed in the C
samples stored at 40 C for 2 weeks, with no additional
precipitate noticed in the 4 and 20 C samples. In contrast,
the B samples were not hazy at any temperature after
2 weeks of incubation.
Again at 10 weeks, detailed visual inspections were
performed on all samples. Table 2 summarizes these
observations, and Figure S2 in the ESM shows digital
images of representative samples from each formulation. In
all but a few cases, at least some precipitate that settled to
the bottom of the vial upon storage was noticed. The only
exception to this observation was the C and B5 samples
incubated at room temperature; however, both of these
formulations were hazy, suggesting that a precipitate was
formed but was small enough in particle size to stay sus-
pended. Except for the C samples, the trend of increasing
precipitate with increasing temperature was a consistent
observation. Based on preliminary tests, this precipitate
was soluble in methanol and water, but not chloroform.
Similar observations were seen after 29 weeks, although
the amount of precipitate increased over time.
3.2 GC-MS Liquid Phase Analysis of DMTS
Formulation (Stability Study)
During the course of the stability study, GC-MS was used
to quantify DMTS and DMDS (a potential degradation
product) in liquid, headspace, and vial cap extracts from
DMTS-PS80 formulations stored in glass vials within
sealed secondary glass vials. DMDS levels, when detected,
were below the limit of quantitation of 10 lg/ml. It was not
possible to quantitate dimethyl tetrasulfide in samples
because this compound was not commercially available.
The initial concentrations of DMTS in each of the DMTS-
PS80 formulations measured by GC-MS are summarized in
Fig. 2. The DMTS concentration in each formulation was
below the nominal 50 mg/ml concentration, suggesting that
some of the DMTS was lost during preparation.
To determine the impact of laboratory, temperature,
presence of buffer, and pH, the stability of each
Fig. 1 Images of DMTS-PS80 water formulations prepared by each
laboratory at the start of the stability study show some evidence of
instability. Shown are representative samples from each of the three
PS80 DMTS formulations prepared by each laboratory from a bottom
view (B formulation, far left; A formulation, middle; C formulation,
far right). The A samples (middle) were prepared in a slightly
different outer vial that allowed additional headspace between the
inner and outer vial. This is more clearly illustrated in Figure S2 in the
Electronic Supplementary Material. The arrow points to a white solid
precipitate apparent in a C sample. DMTS dimethyl trisulfide
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formulation was followed over time. At each time point, a
fresh sample was unsealed, and the concentration of DMTS
in the liquid portion of the formulation was determined as
described in the Methods section. We then performed a
series of statistical tests to determine the impact of each of
these parameters. Table S1 in the ESM lists means and
95 % confidence intervals for the recorded concentration
levels, and Table S2 lists the means and 95 % confidence
intervals for the percent change for each week and storage
temperature combination for each formulation. Figure 3
displays the percent change in concentration for each of the
formulations. A general trend of DMTS concentration
reduction in all formulations over time is evident from
these plots. However, there are some anomalous patterns
(e.g., B formulation at week 4 and week 6) where con-
centration reduction is not monotonically decreasing. There
is some visual evidence of greater loss at the high tem-
perature conditions on later days, but this is not universal
for all formulations and time points.
To determine the impact of the formulation variables
(buffer and pH) and condition variables (laboratory and
temperature) on the concentration change of DMTS in the
liquid phase over time, two general statistical approaches
were performed on the data illustrated in Fig. 3. First,
pairwise comparisons were performed at each time point
(Table S3 and S4 in the ESM). Second, the rate at which
the DMTS concentration decreased as a function of time
was compared between formulations (Tables 3, 4, 5). This
allowed us to follow the overall trend of the data over time
as opposed to treating each time point individually. For
these comparisons, a linear model was fit based on visual
inspection of the data and confirmed with residual plots.
In all cases, the statistical tests included the use of the
simultaneous confidence intervals, which reduces the
likelihood of identifying results as significant based solely
on the number of comparisons being made. For the set of
comparisons at each time point/temperature combination,
the interpretation of the results should be that there is no
more than a 1 in 20 chance that the statistically significant
results observed could have occurred by random chance.
While results observed as statistically significant are
meaningful in the context described above, lack of signif-
icance cannot be interpreted as proof of no difference. It is
possible that true differences exist that have low proba-
bility of appearing as statistically significant because of the
limited number of replicate tests per time point/temperature
combination, and the level of variability in the recovery
process.
In general, we saw an increased rate of DMTS loss with
increasing temperature for all formulations (Table 3).
However, after adjusting for multiple comparisons, most
differences in slopes between formulations stored at dif-
ferent temperatures were not found to be significant
(Table 4), likely due to the spread in the slope predictions
from the model. However, there were a few exceptions to
these findings. For example, the A samples showed sta-
tistical differences between the 2–8 C and 40 C storage
temperatures (Table 4). Further, when the data at week 29
for the room temperature storage for B, A, and C are
included in model fits, the differences in slopes between A
at room temperature and 40 C, C at 2–8 C and room
temperature, and C at room temperature and 40 C all
become statistically significant. In contrast, because of the









B 2–8 ? Clear
20 ? Clear
40 ?? Clear
A 2–8 ? Clear
20 ? Clear
40 ??? Clear
C 2–8 ??? Very hazy
20 - Hazy
40 ??? Clear
B5 2–8 ? Clear
20 - Hazy
40 ??? Clear
B7 2–8 ? Clear
20 ? Hazy
40 ?? Clear





a Appearance above any precipitate at the bottom of the vial
Fig. 2 Initial formulation concentrations are slightly below 50 mg/
ml. Shown is the initial concentration of DMTS for each formulation
as determined by GC-MS after preparation of the formulation. DMTS
dimethyl trisulfide, GC-MS gas chromatography-mass spectrometry
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adjustment method of p values, the difference in slopes
between A at the 2–8 C and 40 C storage temperatures is
no longer classified as significant when the week 29 room
temperature data are included for B, A, and B. This is
because the addition of the week 29 room temperature data
causes the slopes to change so drastically that the newly
found significant slope differences are so large.
We found variable results for the impact of laboratory
preparation. Based on pairwise comparisons (Table S3), we
found significant differences in percent change in concen-
tration between C and B samples for week 2 at the 2–8 C
and room temperature storage and at all storage tempera-
tures for weeks 4, 6, and 10. The direction of difference
was a greater reduction for C samples at weeks 2, 6, and
10, and less of a reduction for C samples at week 4. There
were also significant differences in percent change in
concentrations between A and B samples for the 40 C
storage temperature for week 2, for all storage temperatures
for week 4, and for the room temperature and 40 C stor-
age temperature for weeks 6 and 10. The direction of dif-
ference was a greater reduction for A samples in all cases
except for week 2 at the 2–8 C and room temperature
Fig. 3 The concentration of DMTS in the liquid phase declines over
time. Shown is a graph of the percent change in DMTS concentration
over time as determined by GC-MS for each formulation: formulation
A (panel a), formulation B (panel b), formulation C (panel c),
formulation B5 (panel d), formulation B7 (panel e), and formulation
B9 (panel f). For each formation, sample percent changes from
triplicate samples for each week at each temperature condition are
plotted. DMTS dimethyl trisulfide
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conditions. When we compared the overall trends (Table 5)
over time, only the rates from the A and B samples at
40 C were significantly different. Thus, we did find some
evidence that where the formulation was prepared could
have a significant impact on its stability. However, this
trend was not uniform at each time point and temperature,
and the overall linear rates were not significantly different
in most cases.
While the laboratory that prepared the formulation did
not show a dramatic impact on the stability of the formu-
lation, the presence of buffer did seem to have a negative
impact on the stability of the formulation. Pairwise com-
parisons for B5, B7, and B9 formulations compared with
the B formulation were all observed to be reduced at week
2 to a greater extent than B samples for all temperatures,
with almost all comparisons statistically significant
(Table S4). During week 4, the differences between percent
changes in concentration in the buffered formulations and
unbuffered B formulations were all positive (less degra-
dation for B5, B7, and B9 than for B) as a result of a very
large drop in B concentration. We do not know the reason
for this drop in concentration for B, although the DMTS
concentration would be unlikely to drop then rise again
over time, suggesting that the week 4 data for B samples
may not be reliable. After week 4, the buffered formula-
tions returned to having a greater reduction than for B in
almost every case, with 11 of the 18 differences
statistically significant (Table S4 in the ESM). When we
considered the overall rate (Table 5), the difference in
slopes between B9 and B samples at 40 C and the dif-
ference in slopes between B and A samples at 40 C were
found to be statistically significant. Further, when the data
at week 29 for the room temperature storage for A, B, and
C are included in model fits, the differences between slopes
of B5 and B formulations, B7 and B formulations, and B9
and B formulations at the room temperature storage
become significant. Thus, in general, addition of buffer to
the formulation (at any pH) seems to have a negative
impact on the stability of the formulation.
In contrast to the finding that the presence of a light
buffer in the formulation possibly has a negative impact on
stability, the actual pH of the formulation did not seem to
impact the stability. In general, the average rates of DMTS
loss increased with increasing pH at high temperatures and
slightly decreased at lower temperatures (Table 3), but the
confidence intervals in these rate predictions were wide
enough that this trend was not statistically significant. This
lack of statistical difference is demonstrated in Table 5, in
which no significant differences in rate were observed at
Table 3 Linear coefficient for each formulation and temperature
combination with 95 % confidence intervals
Formulation Temperature Linear coefficient with 95 % CI
B5 2–8 C –1.37 (–1.86 to –0.87)
Room temperature –1.41 (–1.91 to –0.92)
40 C –1.60 (–2.09 to –1.11)
B7 2–8 C –1.25 (–1.75 to –0.76)
Room temperature –1.56 (–2.05 to –1.07)
40 C –1.81 (–2.30 to –1.32)
B9 2–8 C –1.18 (–1.67 to –0.68)
Room temperature –1.46 (–1.95 to –0.97)
40 C –1.99 (–2.48 to –1.50)
B 2–8 C –0.81 (–1.30 to –0.32)
Room temperature –0.69 (–1.19 to –0.20)
40 C –0.68 (–1.17 to –0.19)
A 2–8 C –1.13 (–1.63 to –0.64)
Room temperature –1.52 (–2.02 to –1.03)
40 C –2.30 (–2.79 to –1.81)
C 2–8 C –1.46 (–1.95 to –0.97)
Room temperature –1.40 (–1.8915 to –0.906)
40 C –1.82 (–2.31 to –1.33)
CI confidence interval
Table 4 p values for differences in slope estimates between storage
temperature by formulation
Treatment combination comparison Adjusted p value
B5 2–8 C vs. B5 RT 1.000
B5 2–8 C vs. B5 40 C 1.000
B5 RT vs. B5 40 C 1.000
B7 2–8 C vs. B7 RT 1.000
B7 2–8 C vs. B7 40 C 1.000
B7 RT vs. B7 40 C 1.000
B9 2–8 C vs. B9 RT 1.000
B9 2–8 C vs. B9 40 C 0.842
B9 RT vs. B9 40 C 1.000
B 2–8 C vs. B RT 1.000
B 2–8 C vs. B 40 C 1.000
B RT vs. B 40 C 1.000
A 2–8 C vs. A RT 1.000
A 2–8 C vs. A 40 C 0.048a,b
A RT vs. A 40 C 1.000b
C 2–8 C vs. C RT 1.000b
C 2–8 C vs. C 40 C 1.000
C RT vs. C 40 C 1.000b
RT room temperature
a The difference in slopes is significant at the overall 0.05 signifi-
cance level
b The difference in slopes changes significance when week 29 for B,
A, and C at the room temperature storage are included in the model
fits
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any temperatures when the B5, B7, and B9 formulations
were compared. Thus, the pH of the formulation did not
seem to have an impact on stability. This finding is con-
sistent with preliminary data of the stability of this DMTS
formulation in unbuffered formulations varying from pH 2
to 11 (Petrikovics, 2014, unpublished data).
3.3 Vapor Phase Analysis of DMTS formulations
The DMTS-PS80 test samples for the stability analysis were
prepared with very little headspace in order to minimize
potential DMTS and DMDS vapor losses; therefore,
evaluating the concentration of DMTS and DMDS vapor
above these liquid formulations was not possible. It should
be noted that the vapor pressure of DMDS, DMTS, and
dimethyl tetrasulfide at 25 C is 3.8, 0.14, and 0.007 kPascals
(kPa), respectively; the vapor pressure of DMDS is nearly 27
times the vapor pressure of DMTS and nearly 560 times the
vapor pressure of dimethyl tetrasulfide at 25 C. To deter-
mine whether evaporation into the headspace was causing
loss of DTMS, vials of DMTS-PS80 (50 mg/ml DMTS)
were prepared with 0.4 ml headspace (1.6 ml liquid volume)
and analyzed using GC-MS with the same composition of
formulation B. Little, if any, DMDS (well below the limit of
quantitation, 10 lg/ml) was found in any of the headspace
samples collected from the vials containing formulated
DMTS. Levels of DMTS following 24–48 h of incubation
detected in headspace samples were variable, ranging from
45 to 91 lg DMTS/ml.
Thus, with 80 mg of DMTS initially in the liquid phase
(50 mg/ml 9 1.6 ml) and only 18–36 lg in the headspace
(45–91 lg/ml 9 0.4 ml), approximately only 0.3 % of the
DMTS evaporated into the headspace of the inner vial.
Although we suspect 24–48 h is long enough for the sys-
tem to reach equilibrium (in a perfectly sealed system), we
currently do not know the impact of a longer incubation
time. However, Table 3 suggests that the loss of DMTS in
the liquid phase is approximately 1 % per day (depending
on time and temperature), so the loss of DMTS from
evaporation may be significant. Further, the headspace
within the secondary vials of the B samples was analyzed
at the end of the stability study using GC-MS to determine
whether any leaking occurred from the inner vial to the
outer vial. DMDS and DMTS were not detected in any of
the headspace samples collected from the secondary vials,
although a detailed study and time course were not
performed.
In addition to measuring the vapor phase concentration
of selected samples, the remaining volume of the A, B, and
C samples that had been stored at room temperature was
measured at the end of the stability study (29 weeks)
(Table S5 in the ESM). On average, 3.4 % of the volume
(0.068 ml) was lost (possibly from evaporation), with a
slightly higher volume loss in A samples than in the other
samples. The potential ramifications of this are presented in
the discussion section.
3.4 Analysis of Precipitate
A white precipitate formed over time in the vials con-
taining DMTS-PS80 formulations. The precipitate was
isolated after approximately 30 weeks from three A sam-
ples that were stored at 40 C, dissolved in 1 ml of
methanol, and then analyzed using GC-MS. Trace levels of
DMDS (not quantifiable) were detected in the solubilized
Table 5 p values for differences in slope estimates between formu-
lations by storage temperature
Treatment combination comparison Adjusted p value
B5 2–8 C vs. B7 2–8 C 1.000
B5 2–8 C vs. B9 2–8 C 1.000
B5 2–8 C vs. B 2–8 C 1.000
B7 2–8 C vs. B9 2–8 C 1.000
B7 2–8 C vs. B 2–8 C 1.000
B9 2–8 C vs. B 2–8 C 1.000
B 2–8 C vs. A 2–8 C 1.000
B 2–8 C vs. C 2–8 C 1.000
C 2–8 C vs. A 2–8 C 1.000
B5 RT vs. B7 RT 1.000
B5 RT vs. B9 RT 1.000
B5 RT vs. B RT 1.000a
B7 RT vs. B9 RT 1.000
B7 RT vs. B RT 0.578a
B9 RT vs. B RT 1.000a
B RT vs. A RT 0.747
B RT vs. C RT 1.000
C RT vs. A RT 1.000
B5 40 C vs. B7 40 C 1.000
B5 40 C vs. B9 40 C 1.000
B5 40 C vs. B 40 C 0.390
B7 40 C vs. B9 40 C 1.000
B7 40 C vs. B 40 C 0.064
B9 40 C vs. B 40 C 0.012b
B 40 C vs. A 40 C 0.0003b
B 40 C vs. C 40 C 0.059
C 40 C vs. A 40 C 1.000
Note: the calculations for the slopes did not include data from week 0
or week 29 for the B, A, and C formulations
RT room temperature
a The difference in slopes changes significance when week 29 for B,
A, and C at the room temperature storage are included in the model
fits
b The difference in slopes is significant at the overall 0.05 signifi-
cance level
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precipitate. Moderate levels of DMTS, 385 ± 36 lg
(mean ± standard deviation), were detected in the isolated
precipitate samples. Thus, assuming an initial DMTS mass
of 100 mg in the vial (50 mg/ml 9 2 ml), the amount of
DMTS adsorbed to the cap was found to be only approx-
imately 0.4 %.
3.5 Adsorption Tests
The caps of the vials containing formulated DMTS likely
came into contact with the formulation during sample
preparation or prior to removal of aliquots for analysis
since the vials were filled nearly to the top and some vials
were shipped. Additionally, volatile compounds could have
been adsorbed to the cap. To determine the amount of
DMTS loss due to adsorption, the caps of three of the B7
samples stored at room temperature were separately flash
frozen, pulverized, and then extracted with methanol. Each
methanol extract was analyzed using GC-MS. DMDS was
not detected in any cap extracts. Low levels of DMTS,
31 ± 2 lg total (mean ± standard deviation), were detec-
ted in the vial caps.
3.6 Characterization of the Formulation via DLS
As the GC-MS analyses did not reveal any chemical
degradation products and insufficient amounts to com-
pletely account for liquid phase concentration losses over
time (Fig. 3), we sought to characterize the formulation in
other ways to determine potential destabilization mecha-
nisms. To generally characterize the micellar size of PS80
micelles containing DMTS, DLS was performed. For DLS
analysis, formulation B samples were diluted to *3 % w/v
with water (based on the initial concentration of 15 %
PS80) and analyzed as described in the methods sec-
tion. Consistent with what others have reported [6], we
found the average diameter of a PS80 micelle (without
addition of DMTS) to be approximately 8.7 nm (Table 6).
When DMTS was added to the formulation, a slight change
in the effective diameter and polydispersity index was
apparent, although no major changes were apparent. After
6 weeks, samples were again analyzed; however, because
of precipitate within the samples as well as drastic differ-
ences in measurements between replicate samples, data
were uninterpretable.
3.7 TEM Analysis
In addition to DLS measurements, TEM was performed to
provide a more comprehensive analysis of the micellar
structures within the samples. In general, macroscopic and
DLS observations were consistent with TEM analyses.
Initial attempts included negative stain TEM of neat
(undiluted) samples as well as samples diluted 1:1 with
distilled water. Unfortunately, these samples were too
viscous for negative stain TEM and cryo-TEM because the
high viscosity of the formulation did not allow proper
wicking of the samples to produce a consistent thin film on
the grid prior to vitrification. Thus, although images were
obtained (not shown), they were not analyzed because of
the high likelihood of artifacts being present. A third
attempt involved diluting samples 1:10 with distilled water
prior to analysis. During this dilution, we noticed that the
precipitate material dissolved. Cryo-TEM images showed a
large number of crystalline structures from these samples,
which were thought to be artifacts attributed to the freezing
process. In contrast, negative stain TEM images revealed
that DMTS-PS80 formulations contained larger aggregates
in addition to micelle-like structures, which were absent in
samples containing 15 % PS80 alone (Fig. 4).
Negative stain images of PS80 alone revealed micelles
less than approximately 30 nm (Fig. 4, panel A), which is
consistent with the DLS data (Table 6). In contrast, DMTS-
PS80 formulations showed larger vesicles, suggesting some
agglomeration of micelles due to time or the presence of
DMTS. The rate of formation of these vesicles is unknown,
but in the case of the A samples, uniform vesicles of
approximately 500 nm in size formed at least within
6 weeks of storage (Fig. 4, panel B). Larger structures
were also observed in B and C samples, but the aggregated
structures were less ordered (Fig. 4, panel C and D,
respectively).
3.8 NMR Analysis
NMR analysis was also performed on selected samples to
provide overall structural information on the entire for-
mulation, including DMTS, PS80, and any degradation
products that may be present. Initial 1H and 13C NMR
spectra were obtained by dissolving DMTS alone, PS80
alone, or DMTS and PS80 in combination in D2O. These
Table 6 Characterization of
DMTS-PS80 formulation via
dynamic light scattering
Formulation Effective diameter (nm) Polydispersity Index
PS80 alone 8.7 0.17
DMTS-PS80 (formulation B) 11.6 0.19
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spectra showed that the DMTS signals for both proton and
carbon spectra (Figure S3 in the ESM) were clearly
resolved and identifiable in the formulation. The proton
spectra revealed that direct analysis of the formulations (in
H2O) was feasible using solvent suppression techniques (to
prevent dominance of the water signal and obscuring of
other signals of interest), since the water signal
(*4.7 ppm) was resolved from the rest of the peaks in the
formulation (Figure S4 in the ESM). The solvent sup-
pression technique allowed direct analysis of the formula-
tions with resolution gained in the water region of the
spectra (3.4–6 ppm), thus allowing NMR to be used for
direct interrogation of the DMTS and PS80 present.
Figure 5 shows the peak assignments for DMTS and
PS80 based on previously reported spectra [7, 8]. DMTS
resonates as a single peak since all protons are equivalent
within the molecule. PS80 commercial preparations are
actual mixtures of related compounds, with inexact
ethoxylation. The majority of the hydrophobic tail is
composed of oleate (*72 %), but linoleate, linolenate, and
sterate can also comprise a portion of this moiety.
Although PS80 is mixture of several different structures,
107 protons of the theoretical 118 protons could be
assigned. The unassigned proton signals are likely within
the water region (e.g., hydroxyl protons) or less distinctly
convoluted with other proton resonances.
To determine whether degradation products of DMTS
and/or PS80 appeared following incubation, several sam-
ples were analyzed by 1H NMR after 6 weeks and
10 weeks. Triplicate samples from the 6-week stability
time point prepared by each lab as well as a freshly pre-
pared formulation were compared, and all replicates
showed very consistent spectra (Figure S5 in the ESM).
The 6-week B sample is shown; data for others are not
shown. This consistency suggests that single samples were
representative of each of the triplicate samples and could
be used for comparative purposes. Comparison of 1H
spectra of the various formulations (between labs) revealed
only slight differences between A, B, and C samples (fol-
lowing 6 weeks of incubation at room temperature, Fig. 6).
In general, the B samples and C samples appeared to be
more similar to the freshly made controls, but only very
minor differences were apparent. A close inspection of the
DMTS region revealed a very small amount of dimethyl
tetrasulfide (2.571 ppm) and DMDS (2.325 ppm) (based on
resonance reported by Argyropoulos et al. [7], as shown in
Fig. 7. Since the satellite peaks at 2.332 and 2.613 ppm,
which are due to the natural abundance of 13C, are *1 %
of the main DMTS peak, the overall concentrations of the
tetrasulfide and disulfide are *0.1 to 0.2 % of the DMTS
peak. These data are consistent with the GC-MS data,
which showed very little accumulation of these two
degradation products. In fact, small amounts of the tetra-
sulfide (2.57 ppm) and the disulfide (2.325 ppm) were
present in freshly made controls as well (not shown) and
again are consistent with the GC-MS data.
Fig. 4 DMTS-PS80 formulations form vesicles. Shown are repre-
sentative negative stain TEM images from freshly prepared PS80
(panel a), as well as B samples (panel b), formulation A samples
(panel c), and formulation C samples (panel d) that were stored at
2–8 C for approximately 6 weeks. The black line in each image is
500 nm in size. TEM transmission electron microscopy
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Fig. 5 DMTS-PS80
formulation can be analyzed via
NMR without D2O exchange.
Shown is a representative
spectra of a DMTS-PS80
formulation (in H2O with
1H
NMR peak assignments for
DMTS and PS80). The numbers
above the colored identifiers
indicate theoretical integration
values, and red numbers below
represent actual normalized to
the expected value of 3 for the
terminal methyl group of the
oleate moiety of PS80. DMTS
dimethyl trisulfide, NMR
nuclear magnetic resonance
Fig. 6 NMR Spectra of DMTS-PS80 formulations prepared by
different laboratories are similar before and after 6 weeks of storage.
Shown is the 1H NMR spectral comparison of A samples (green
trace), B samples (red trace), and C samples (purple trace) following
6 weeks of storage compared with a freshly made control (blue trace).
The insets show slight variations in minor peaks between formula-
tions. DMTS dimethyl trisulfide, NMR nuclear magnetic resonance
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As with the GC-MS analyses, the NMR did not reveal
any striking accumulation of chemical degradation prod-
ucts. Additionally, using the assumption that the PS80 was
not significantly degrading over time compared with
DTMS, the NMR spectra could also be used to determine
the DMTS concentration using selected signals as descri-
bed in the methods section. As shown in Figure S6 in the
ESM, the GC-MS and NMR data generally correlated with
each other.
In addition to soluble material, the precipitate was
analyzed by NMR by dissolving the precipitate (separated
from the bulk liquid by centrifugation) from an A sample
(after 10 weeks of storage at 40 C) in deuterated metha-
nol. This sample was compared with the soluble material
diluted into D2O. As shown in Figure S7 in the ESM, both
the soluble material and isolated solid contained similar
ratios of DMTS and PS80, and an overall similar compo-
sition (with minor shifts due to solvent effects of D2O and
d4-methanol). However, the insoluble material was not
rinsed of residual soluble material (since a suitable washing
solvent could not be determined). Thus, the NMR signal
may have in fact been merely due to the residual liquid
remaining, and the precipitate may have contained com-
pounds without protons. Preparation of a larger amount of
bulk precipitate would be needed to analyze this material
further from an NMR standpoint.
3.9 SEC-HPLC Analysis
To determine whether degradation to the PS80 component
of the formulation occurs over time, selected samples were
also analyzed by SEC-HPLC and CMC analysis. The
simple SEC-HPLC method, originally reported by Tani
et al. [5], allows the determination of PS80 concentration in
the formulation through the use of a mobile phase con-
taining PS80 above its CMC. Our data revealed a linear
response of absorbance of the main PS80 peaks as a
function of PS80 concentration in the range of 0.5–10 %
w/v, with an R2 value of 0.994 (Figure S8 in the ESM). To
determine whether the PS80 was degrading over time,
SEC-HPLC data were collected for the samples prepared
by each lab following 6 and 10 weeks of incubation at
room temperature and compared with a freshly made
control. Figure 8 shows the concentration of PS80
remaining in each formulation analyzed. We found similar
patterns between 6-week-old (not shown) and 10-week-old
samples, with no additional loss in PS80 from 6 to
10 weeks. In all cases, a slight loss in PS80 is apparent
with increasing temperature (Fig. 8). Further, the A sam-
ples showed a much lower amount of PS80 remaining than
with the other laboratory preparations. While the reason for
this loss is unknown, it may be due to disintegration of the
micelle or to loss of vesicles upon filtration prior to SEC-
HPLC analysis. We filtered samples with a 0.2-lm filter
prior to SEC-HPLC analysis, and TEM analysis suggests
that the A, B, and C samples formed vesicles of nearly
0.5 lm in size, with the A samples having more ordered
structures. Thus, the possibility exists that the loss seen
with the B samples was due to loss during filtration.
Nonetheless, these results suggest that different PS80
sources and/or laboratory manipulation can lead to differ-
ences in formulation stability over time.
Fig. 7 The disulfide and tetrasulfide derivatives of DMTS represent
minor components of the formulation following 6 weeks of incuba-
tion. Shown is the 1H NMR spectra of the DMTS region of a B
formulation following 6 weeks of storage at room temperature. Based
on comparison with the DMTS peak, the overall concentrations of the
tetrasulfide and disulfide are *0.1 to 0.2 % of the DMTS concen-
tration. DMTS dimethyl trisulfide, NMR nuclear magnetic resonance
Fig. 8 The solution stability of PS80 within the DMTS PS80
formulation is laboratory and temperature dependent. Shown is the
concentration of PS80 in triplicate samples of DMTS PS80 formu-
lations prepared by three different laboratories after 10 weeks of
storage at various temperatures. The red line indicates the starting
concentration of 15 v/w. Values are ± standard deviation. DMTS
dimethyl trisulfide
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A closer investigation of the chromatograms between
the A and B samples demonstrated that following the main
peak, a small valley followed by a slight increase in
absorbance was apparent in the A samples that was not
apparent in the other samples (Fig. 9). This pattern can be
indicative of PS80 degradation [5], as smaller micelles of
PS80 will migrate more slowly than larger ones, and when
the PS80 concentration reaches the level below the mobile
phase concentration (0.1 %), a negative peak will occur.
3.10 CMC Analysis
In addition to SEC-HPLC analysis, CMC assays were
performed to determine whether the CMC of the PS80
component of the formulations changed as a function of
time, temperature, or pH. For these analyses, the CMC is
determined using fluorescence polarization. The formula-
tion is diluted in water in the presence of a fluorescent
probe that includes an aliphatic tail that is inserted into the
micelle upon formation. Because fluorescence polarization
is indirectly proportional to a molecule’s rotation speed, a
sharp increase in fluorescence polarization is apparent at its
CMC (Figure S9 in the ESM). Figure 10 demonstrates no
significant difference between a freshly prepared DMTS-
PS80 formulation and one of PS80 alone, suggesting that
DMTS does not change the CMC based on this assay. The
calculated concentration of PS80 of 0.12 % is in good
agreement with published values of 0.07–0.2 % [5, 9, 10].
However, DMTS was diluted during these analyses to
concentrations below 1 mg/ml. This dilution was needed
because of the low solubility of DMTS in water. Further,
upon dilution, any precipitated material was fully
Fig. 9 The HPLC trace of
DMTS formulations after
10 weeks of storage is
laboratory dependent. Shown
are representative HPLC traces
from 10-week-old B (panel
a) and A samples (panel
b) stored at 2–8 C. DMTS
dimethyl trisulfide, HPLC high-
performance liquid
chromatography
Fig. 10 Slight increases in CMC of the DMTS-PS80 formulation are
due to time and temperature. Shown are the calculated CMC
concentrations for various DMTS-PS80 formulations (A, B, or C at
various temperatures) in comparison with PS80 or PS20 alone. CMC
concentrations were calculated as described in the Sect. ‘‘2’’. CMC
critical micelle concentration, DMTS dimethyl trisulfide
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dissolved, so any increases in CMC could be interpreted as
an actual change to the CMC value and not due to loss of
PS80 from precipitation. A slight increase in CMC was
apparent when samples were stored at any temperature for
a period of 5 weeks (Fig. 10). Further, this slight increase
continued with rising temperatures, suggesting that some
change to the PS80 molecule or micelle was occurring over
time. Similar results were seen with the buffered formu-
lations, and no significant difference was apparent between
buffered conditions (Figure S10 in the ESM).
4 Discussion
Here, we have reported the stability of a DMTS-PS80
formulation over the course of 29 weeks. While the sta-
bility of the DMTS component was fairly independent of
which laboratory prepared the formulation (and potentially
the chemicals used to prepare the formulation), the liquid
concentration of DMTS in the formulation was reduced
36–58 % over the course of 29 weeks in all cases when
stored at room temperature. This loss typically increased
with increasing temperatures, although we did not find
statistical differences between the stability at different
storage temperatures in all cases. Further, we found that
addition of a light buffer negatively impacted the stability,
whereas the pH of that buffer did not significantly impact
stability. Additionally, initial concentrations of DMTS
were less than the target concentration of 50 mg/ml (em-
pirically determined concentration, Fig. 2), suggesting
difficulties in the accurate preparation of DMTS
formulations.
The reduction of DMTS concentration could be due to a
number of factors, including chemical degradation, evap-
oration, precipitation, and/or adsorption. To determine a
potential destabilization mechanism, we used a number of
analytical methods to characterize the formulations
throughout the stability study. Table 7 summarizes the
evidence for each of the mechanisms based on the data
collected during this study, and each of these mechanisms
are described in more detail following the table.
4.1 Chemical Degradation
Previous studies have revealed that the major chemical
degradation components of a self-assembled micellar for-
mulation of diallyl trisulfide (DATS) are diallyl disulfide
(DADS) and diallyl tetrasulfide [11]. This formulation was
prepared with PS80 and co-solvents and heated to 100 C
for 15 min. While we identified a small amount of the
analogous compounds DMDS and (potentially) dimethyl
tetrasulfide, the concentration of these degradation prod-
ucts did not substantially increase over time, suggesting
that a similar chemical degradation mechanism to DATS
was not an overriding factor for the decrease in DMTS
solution concentration over time. Further, no other
Table 7 Potential mechanisms for reduction of DMTS concentration in DMTS-PS80 formulations
General
mechanism
Evidence for Evidence against
Chemical
degradation
No substantial evidence Very little formation of dimethyl disulfide or
dimethyl tetrasulfide over time
No major chemical degradation products
identified by NMR or GC-MS
Addition of buffer did not stabilize formulation
Stability did not change with pH
Evaporation When outer vial is opened, DMTS smell is apparent, suggesting leaking into
outer vial
Some A samples, which were contained in slightly larger outer vials,
contained condensate and showed larger reduction in DMTS concentration
over time
Some DMTS detected in headspace measurements
*2 to 5 % volume loss after 29 weeks
Large amounts of DMTS not detected in
headspace measurements
Precipitation Precipitation increased over time and with increasing temperature
Large vesicle formation demonstrated in TEM images
Precipitate composed of DMTS and PS80
Only a small amount of DMTS (385 ± 36 lg
DMTS, N = 3) found in precipitate material
Adsorption Some DMTS found in vial caps Only 31 ± 2 lg DMTS (N = 3) extracted from
vial caps
DMTS dimethyl trisulfide, GC-MS gas chromatography-mass spectrometry, NMR nuclear magnetic resonance, TEM transmission electron
microscopy
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degradation products were revealed by GC-MS or NMR,
and pH did not seem to impact the stability of the formu-
lation. However, unknown chemical degradation products
or reactive species may be highly volatile or unde-
tectable by GC-MS or NMR. For example, dimethyl
disulfide (DMDS) has been shown to react with sulfur to
form dimethyl polysulfides under high pressure and high
temperature conditions [12]. Thus, a deeper investigation
into the presence of elemental sulfur and/ or polysulfides in
the formulation may be warranted. Although we see no
gross evidence of this based on NMR, other methods such
as LC-MS may be needed to fully characterize any other
chemical species present in the system.
The presence of oxidizing compounds could potentially
react with DMTS. Ju et al. [11] showed that addition of
antioxidants to micellar preparations of diallyl trisulfide
does not elicit stabilization, suggesting that the presence of
oxidants did not contribute to degradation. However,
Kruger et al. [13] demonstrated that an aqueous solution of
dimethyl disulfide could be partially degraded in the
presence of hydrogen peroxide, but degradation conditions
were fairly extreme (low pH, 60 C, and high concentra-
tions of hydrogen peroxide). Similarly, Adewuyi and
Carmichael [14] showed oxidation of dimethyl sulfide by
hydrogen peroxide under acidic conditions.
Oxidizing compounds such as peroxides may contami-
nate PS80 during preparation [15] and may form during
storage [16], but only at low levels. Further, PS80 can be
degraded via autoxidation and hydrolysis, but typically
higher temperatures and extreme pHs are needed for sub-
stantial degradation [17, 18]. In our analysis, we see no
gross evidence of loss of 1H NMR signal of protons from
the fatty ester moiety in signal over time (Fig. 6), although
a more detailed analysis would be needed to look for minor
changes in NMR profiles within this region. In addition, we
see very little drop in the CMC of PS80 over time, sug-
gesting that hydrolysis is not occurring to significant levels.
Although SEC-HPLC analysis suggests that the A samples
had a substantial reduction in PS80 concentration, this may
be due to precipitation as discussed further below.
4.2 Evaporation
Although chemical degradation of DMTS does not seem to
be an overriding factor for the instability of the formula-
tion, evaporation may be a concern because of the rela-
tively high volatility of DMTS in aqueous solutions. While
DMTS is a volatile compound, assembly into micelles
should dramatically lower its volatility. PS80 increases the
solubility of DMTS in aqueous solution, and our DLS
results indicate a slight increase in micelle size upon
addition of DMTS, which suggests that DMTS is in fact
partitioning into micelles. However, the fraction of DMTS
that partitions into micelles is unknown, although it can be
inferred that the fraction that partitions into micelles is
likely high since solubility is increased approximately an
order of magnitude or more. Nonetheless, the small frac-
tion of DMTS in the bulk water phase could evaporate over
time, and as the system reaches equilibrium, DMTS within
the micelle is displaced to replenish evaporated DMTS.
Thus, even though the formulation is micellar, volatiliza-
tion of DMTS is still a concern.
Despite taking steps to reduce or eliminate evaporation,
we found some evidence that evaporation was occurring.
Physical observations included a DMTS smell when the
outer vials were opened for analysis. However, the odor
threshold for DMTS is very low, approximately 5–10 ng/l
[19, 20]. Further, we noticed the buildup of a small amount
of condensate in the outer vials of some samples. Overall,
we measured a 2–5 % drop in the total volume of the
formulation after 29 weeks at room temperature. Since the
vapor pressure of DMTS is higher than water, the DMTS in
the bulk phase would likely preferentially evaporate over
water. Further, the initial DMTS fraction of the formulation
is only approximately 4 %, so a small drop in volume
could contain a significant proportion of DMTS.
The most substantial evidence is the fact that GC-MS
measurements revealed small amounts of DMTS contained
in the headspace of the DMTS-PS80 formulation-contain-
ing vials. If the inner and outer vial system is completely
sealed, equilibrium should be reached between gas and
liquid phase. However, if the outer vial is not completely
sealed, equilibrium may never be reached. Jin [21]
demonstrated that solubilization of volatile organic com-
pounds in aqueous PS80 solutions reach equilibrium
between the aqueous phase (including equilibrium between
micellar concentration and bulk aqueous concentration)
and gaseous phase after a few hours of shaking, and
addition of co-solvents had little to no effect on aqueous–
gas partitioning.
Given the micellar arrangement of the formulation,
future characterization should include determination of
Henry’s law constants and micelle–water partition coeffi-
cients. Henry’s law constant would measure the ratio of
DMTS in the vapor and liquid phase, and could be mea-
sured in the presence and absence of PS80 to determine
whether micelle preparation reduces evaporation in a
similar manner as reported by Vane and Giroux [22].
Further, such measurements allow determination of the
fraction of DMTS that partitions into micelles (fm). Vane
and Giroux [22] reported that 23 % of benzene partitioned
into micelles in the presence of 1.3 % Tween 20, and 49 %
of toluene partitioned into micelles. Similar results were
demonstrated for trichloroethylene, and as the detergent
concentration increases, fm increases. Determination of
these parameters in the current formulation and any future
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developed formulations would allow for optimization of
volatility reduction.
In general, alternative surfactants and/or addition of co-
solvents could be used to both increase solubility and
partitioning into micelles. However, to rule out evaporation
as a source of formulation instability, completely air tight,
fully sealed vials should be tested, or heavier gases, such as
argon, could be used in place of nitrogen. Alternatively,
DMTS could be encapsulated to reduce volatility. Encap-
sulation of volatile compounds into cyclodextrins [23] or
gum arabic/chitosan [24] capsules has proven useful for
volatility reduction.
4.3 Precipitation
Since the solubility of DMTS in water is low, the addition
of a detergent such as PS80 is critical to increase solubility.
The current formulation increases the solubility to
approximately 50 mg/ml, but precipitation is still a con-
cern. The noticeable haziness in each sample is likely due
to the formation of small particles that stay suspended.
According to several reports, the cloud point of PS80 is
65 C [10] or higher, with one report suggesting that the
cloud point is[100 C for neat PS80 in water [25]. The
impact that DMTS has on the cloud point is unknown.
Thus, future characterization of this and other DMTS-PS80
formulations should include cloud point determination to
ensure that DMTS does not substantially lower the cloud
point.
TEM analyses demonstrated that larger particles can
form within the formulation. Unfortunately, reliable data
were not obtained immediately following formulation
preparation. Thus, the rate of formation of these vesicles is
unknown, although precipitated material could be due to
large vesicles being formed and eventually falling out of
solution. Similar vesicles were observed by Won et al. [26]
for poly(ethylene oxide)-water-based formulations and Rai
and Yasir [27] for drug-loaded oleic acid-Tween-80
emulsifications. Thus, while the addition of DMTS may
initially cause only a minor increase in micelle size
(Table 6), these micelles may aggregate into larger struc-
tures over time. However, to substantiate this claim, a more
rigorous analysis of the formulation is needed.
Based on NMR analysis, the precipitate that forms
contains both DMTS and PS80, although we cannot rule
out the possibility that we were merely analyzing the
residual liquid. Further, only moderate levels of DMTS,
385 ± 36 lg (mean ± standard deviation), were detected
in the isolated precipitate via GC-MS. In general, addition
of co-solvents, such as those used with compounds similar
to DMTS [1, 11], may be beneficial to enhance the solu-
bility of DMTS and reduce precipitate formation, and
should thus be considered in future formulations.
4.4 Adsorption
In addition to evaporation and precipitation, we considered
the possibility that the reduction of DMTS concentration in
the bulk phase could be due to adsorption. The presence of
PS80 should reduce adsorption of DMTS, but to investigate
this possibility, we studied the adsorption of DMTS in the
formulation to the inner vial caps. DMDS was not detected
in any cap extracts, and only low levels of DMTS were
detected in the vial caps, suggesting that adsorption to the
caps may be a minor contributor to the loss of DMTS. We
did not investigate the adsorption to the glass walls of the
vial, although we assume that this is unlikely because of
the presence of a high amount of surfactant in the formu-
lation. However, we cannot rule this out as a possibility,
and future tests could focus on determining adsorption. A
detailed investigation of different tubes may be advanta-
geous to select the best container that results in the lowest
possible adsorption of DMTS and/or whether adsorption is
leading to loss of DMTS from the solution.
5 Conclusions
Based on the results of this study, we have shown that
storage temperature and potentially laboratory preparation
may have some impact on the stability of the DMTS-PS80
formulation. Therefore, care must be taken during formu-
lation preparation. Further, while pH does not seem to
impact degradation, the addition of a light buffer does seem
to have a negative impact on stability. Based on the data
collected, we suggest that the instability of the formulation
is governed at least partially by precipitation and evapo-
ration, although a combination of factors is likely involved.
Further, we were not able to completely track (i.e., mass
balance) the loss in DMTS over time. Thus, while a
combination of factors is likely, the fate of DMTS within
the current system is yet to be completely understood.
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